T1	Intervention 552 626	patients started to receive dexamethasone, vincristine, and L-asparaginase
T2	Intervention 628 668	Etoposide was administered until Day 22.
T3	Intervention 384 541	In the first week of remission induction therapy, patients received etoposide (50 mg/m(2) per day) administered orally as a single agent once or twice daily.
T4	Intervention 338 382	epipodophyllotoxins during frontline therapy
T5	Intervention 669 786	Two courses of consolidation therapy were followed by continuation therapy or hematopoietic stem cell transplantation
